Baki Enayatullah, Baumgart Lea, Kehl Victoria, Hess Felix, Wolff Andreas Wolfgang, Wagner Arthur, Hernandez Petzsche Moritz Roman, Boeckh-Behrens Tobias, Hemmer Bernhard, Meyer Bernhard, Gempt Jens, Wunderlich Silke
Department of Neurology, Technical University of Munich, School of Medicine and Health, Klinikum rechts der Isar, Munich, Germany
Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stroke Vasc Neurol. 2025 Jun 30;10(3):323-329. doi: 10.1136/svn-2024-003360.
Malignant swelling is a fatal complication that can occur abruptly in space-occupying cerebellar infarction. We aimed to establish markers that predict malignant swelling in cerebellar infarction.
We retrospectively analysed data of stroke patients who were treated in our hospital between 2014 and 2020. Malignant swelling was defined as a mass effect in the posterior cranial fossa, accompanied by a decrease in consciousness due to compression of the brainstem and/or the development of obstructive hydrocephalus. Statistical analyses were performed on multiple variables to identify predictors of malignant swelling.
Among 7284 stroke patients, we identified 487 patients with an infarct in the cerebellum. 93 patients were suitable for analysis having space-occupying cerebellar infarction. 33 of 93 (35.5%) patients developed malignant swelling. Multivariable analysis revealed infarct volume as the main predictor being independently associated with the development of malignant swelling with a cut-off infarct volume of 38 cm being associated with a swelling rate of >50% (OR 32.0, p<0.001). Higher NIHSS (National Institutes of Health Stroke Scale) score on admission (median NIHSS 12 vs 4, OR 1.078; p=0.008) and the presence of additional brainstem infarction (51.5% vs 16.7%, OR 5.312; p=0.013) were associated with the development of malignant swelling in univariate analyses. 13 of 33 (39.4%) cases of malignant swellings occurred after more than 3 days.
Infarct volume was the key significant predictor of malignant swelling in space-occupying cerebellar infarction. With many cases of malignant swelling occurring after more than 72 hours, we advocate prolonged neurological monitoring.
恶性肿胀是一种致命并发症,可在小脑占位性梗死中突然发生。我们旨在建立预测小脑梗死恶性肿胀的标志物。
我们回顾性分析了2014年至2020年在我院接受治疗的中风患者的数据。恶性肿胀定义为后颅窝的占位效应,伴有因脑干受压导致的意识下降和/或梗阻性脑积水的发展。对多个变量进行统计分析,以确定恶性肿胀的预测因素。
在7284例中风患者中,我们确定了487例小脑梗死患者。93例患者因小脑占位性梗死适合进行分析。93例患者中有33例(35.5%)发生了恶性肿胀。多变量分析显示梗死体积是主要预测因素,与恶性肿胀的发生独立相关,梗死体积截断值为38 cm时,肿胀率>50%(比值比32.0,p<0.001)。入院时较高的美国国立卫生研究院卒中量表(NIHSS)评分(中位数NIHSS 12分对4分,比值比1.078;p=0.008)和存在额外的脑干梗死(51.5%对16.7%,比值比5.312;p=0.013)在单变量分析中与恶性肿胀的发生相关。33例恶性肿胀中有13例(39.4%)发生在3天以上。
梗死体积是小脑占位性梗死恶性肿胀的关键显著预测因素。由于许多恶性肿胀病例发生在72小时以上,我们主张延长神经学监测。